Orthopedic Market to Exceed $54 Billion in 2022

By Julie A. Vetalice

Orthopedic Market to Exceed $54 Billion in 2022

ORTHOWORLD® Inc.’s newest installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT® estimates worldwide orthopedic product sales will exceed pre-pandemic levels this year.

ORTHOWORLD Inc. today released public and private orthopedic company sales estimates along with Joint Replacement, Spine, Trauma, Sports Medicine and Orthobiologics market projections in THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT.

The seven largest orthopedic companies—DePuy Synthes, Stryker, Zimmer Biomet, Smith+Nephew, Medtronic, Arthrex and NuVasive—all with revenue exceeding $1 billion annually, control nearly 66% of the market, up almost 3% from a year earlier, according to the report.

Orthopedic Company Revenue

Orthopedic Company Revenue for 2021: Share by Revenue Tier

“Stryker reclaimed the No. 1 position in orthopedics due to its acquisition of Wright Medical,” said Mike Evers, co-author of the report and Digital Content Strategist for ORTHOWORLD. “Globus Medical, Aesculap and an aggressively acquisitive DJO/Enovis are next in line to move up to the $1 billion+ tier.”

In addition to the top tier of companies, ORTHOWORLD specializes in reporting orthopedic sales for dozens of smaller companies such as ATEC, Corin, SeaSpine, Paragon 28, Medartis, ulrich medical and Exactech.

“Proprietary revenue estimates for smaller orthopedic companies remain a vital component of our report,” said Carolyn LaWell, Chief Content Officer at ORTHOWORLD. “Our Members seek to boost their competitive intelligence and identify acquisition targets. Our orthopedic sales estimates for over 30 private companies are essential in providing a thorough review of the orthopedic industry.”

THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT is the definitive source for orthopedic market intelligence.

Source: ORTHOWORLD Inc.